Literature DB >> 2429493

Tissue polypeptide antigen staining of the chordoma and notochordal remnants.

P C Burger, M Makek, P Kleihues.   

Abstract

Tissue polypeptide antigen (TPA) has been increasingly used as an immunological marker for tumors derived from the lining epithelia of body cavities, including those of the gastrointestinal tract and genitourinary and bronchopulmonary systems. Here, we present evidence that this antigen is consistently and strongly expressed by a nonepithelial lesion - the chordoma. Irrespective of their sites, all seven chordomas, including one chondroid lesion, were heavily stained. In contrast, five chondrosarcomas were unstained or showed only focal slight positivity. TPA staining was also found to be strongly expressed by notochordal rests within the intervertebral disks of one newborn and five fetuses (15th to 32nd week of gestation), adding further evidence that these rests are the histogenetic origin of the chordoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429493     DOI: 10.1007/bf00686082

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

1.  Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique; presence of an insoluble, heat-labile tumor antigen.

Authors:  B BJORKLUND; V BJORKLUND
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

2.  Ecchordosis physaliphora. An electron microscopic study.

Authors:  R B Wyatt; S S Schochet; W F McCormick
Journal:  J Neurosurg       Date:  1971-05       Impact factor: 5.115

3.  Chordomas and cartilaginous tumors at the skull base.

Authors:  M J Heffelfinger; D C Dahlin; C S MacCarty; J W Beabout
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

4.  [Tissue polypeptide antigen as a tumor marker of brain tumors].

Authors:  H Sonoda; Y Matsukado; S Uemura; M Kaku
Journal:  Neurol Med Chir (Tokyo)       Date:  1984-09       Impact factor: 1.742

5.  Clinical and pathologic review of 48 cases of chordoma.

Authors:  T A Rich; A Schiller; H D Suit; H J Mankin
Journal:  Cancer       Date:  1985-07-01       Impact factor: 6.860

6.  Chondroid chordoma. Electron-microscopic study of two cases.

Authors:  E Valderrama; L B Kahn; S Lipper; J Marc
Journal:  Am J Surg Pathol       Date:  1983-10       Impact factor: 6.394

7.  Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies.

Authors:  M Miettinen; V P Lehto; D Dahl; I Virtanen
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

8.  Ecchordosis physaliphora and chordoma: a comparative ultrastructural study.

Authors:  K L Ho
Journal:  Clin Neuropathol       Date:  1985 Mar-Apr       Impact factor: 1.368

9.  The clinical value of tissue polypeptide antigen in patients with gynecologic tumors.

Authors:  M Inoue; Y Inoue; K Hiramatsu; G Ueda
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

10.  Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker.

Authors:  K Weber; M Osborn; R Moll; B Wiklund; B Lüning
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

View more
  2 in total

Review 1.  Pediatric cervical chordoma: report of two cases and a review of the current literature.

Authors:  Gwi Hyun Choi; Moon-Sool Yang; Do Heum Yoon; Hyun Chyul Shin; Keung Nyun Kim; Seong Yi; Dong Yeop Lee; Poong Gi Ahn; Yoon Ha
Journal:  Childs Nerv Syst       Date:  2010-01-22       Impact factor: 1.475

2.  Intermediate filament typing of the human embryonic and fetal notochord.

Authors:  W Götz; M Kasper; G Fischer; R Herken
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.